Szczepan Baran

Szczepan Baran

Company: Novartis

Job title: Head of Emerging Technologies


Szczepan Baran is Head of Emerging Technologies at Novartis

In this position, Dr. Baran leads development & implementation of strategic vision for emerging technologies to optimize non-clinical models of efficacy, mechanism, and safety that improve endpoint prediction, reproducibility and clinical predictivity. He spearheads
– digital biomarker and endpoint strategy and alignment with disease areas and clinical franchises
– internal groups and resources for platforms that offer alternatives to traditional pre-clinical modeling, such as microphysiological systems
– & builds high performance cross-functional teams that accelerate validation and readiness of emerging technologies that foster a culture of collaboration and high performance innovation.


PANEL DISCUSSION: The Future of 3D Tissue Model Adoption 12:55 pm

Progress to showcase the application of 3D systems within drug discovery and development across key sectors How is context of use being defined across the model continuum and what are current advantages and limitations between each system type? Addressing the need to balance the compromise between industry throughput requirements and physiological relevancy Future strategies to…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.